Viruses (Aug 2021)
SHARED: An International Collaboration to Unravel Hepatitis C Resistance
- Anita Y.M. Howe,
- Francesca Ceccherini-Silberstein,
- Julia Dietz,
- Stephanie Popping,
- Jason Grebely,
- Chaturaka Rodrigo,
- Johan Lennerstrand,
- Mark W. Douglas,
- Milosz Parczewsk,
- P. Richard Harrigan,
- Jean-Michel Pawlotsky,
- Federico Garcia,
- SHARED Collaborators
Affiliations
- Anita Y.M. Howe
- British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
- Francesca Ceccherini-Silberstein
- Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy
- Julia Dietz
- Department of Internal Medicine 1, University Hospital, Goethe University, 65926 Frankfurt, Germany
- Stephanie Popping
- Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands
- Jason Grebely
- The Kirby Institute, UNSW Sydney, Sydney, NSW 2006, Australia
- Chaturaka Rodrigo
- Department of Pathology, University of New South Wales, Sydney, NSW 2006, Australia
- Johan Lennerstrand
- Department of Medical Sciences, Clinical Microbiology, Uppsala University, 75121 Uppsala, Sweden
- Mark W. Douglas
- Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia
- Milosz Parczewsk
- Department of Infectious Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 70-507 Szczecin, Poland
- P. Richard Harrigan
- Department of Medicine, University of British Columbia, Vancouver, BC V5Z 4R4, Canada
- Jean-Michel Pawlotsky
- National Reference Center for Viral Hepatitis B, C and D, Department of Virology, Henri Mondor Hospital & INSERM U955, 94000 Créteil, France
- Federico Garcia
- Microbiology Department, University Hospital San Cecilio, Instituto de Investigacion Ibs.Granada, 18012 Granada, Spain
- SHARED Collaborators
- British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
- DOI
- https://doi.org/10.3390/v13081580
- Journal volume & issue
-
Vol. 13,
no. 8
p. 1580
Abstract
The advent of direct-acting antivirals (DAAs) has transformed the treatment landscape of hepatitis C [...]
Keywords
